PMID- 14655109
OWN - NLM
STAT- MEDLINE
DCOM- 20040114
LR  - 20060623
IS  - 0015-5659 (Print)
IS  - 0015-5659 (Linking)
VI  - 62
IP  - 4
DP  - 2003 Nov
TI  - Dendritic cells in cancer immunotherapy - a short review.
PG  - 317-8
AB  - Dendritic cells (DCs) are rare leukocytes that are uniquely potent in their 
      recent application to therapeutic cancer vaccines. Isolated DCs loaded with 
      tumour antigen ex vivo and administered as a cellular vaccine have been found to 
      induce protective and therapeutic anti-tumour immunity. In the present report we 
      describe the most common methods of culturing DCs and delivering tumour antigens 
      and we summarise clinical trials of cancer immunotherapy using DCs-based 
      vaccines.
FAU - Wojas, Kamila
AU  - Wojas K
AD  - Department of Clinical Immunology, Medical University, Lublin, Poland. 
      kamilawojas@poczta@onet.pl
FAU - Tabarkiewicz, Jacek
AU  - Tabarkiewicz J
FAU - Rolinski, Jacek
AU  - Rolinski J
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Poland
TA  - Folia Morphol (Warsz)
JT  - Folia morphologica
JID - 0374620
RN  - 0 (Antigens, Neoplasm)
SB  - IM
MH  - Antigens, Neoplasm/immunology
MH  - Dendritic Cells/*immunology
MH  - Humans
MH  - *Immunotherapy
MH  - Neoplasms/immunology/*therapy
RF  - 8
EDAT- 2003/12/05 05:00
MHDA- 2004/01/15 05:00
CRDT- 2003/12/05 05:00
PHST- 2003/12/05 05:00 [pubmed]
PHST- 2004/01/15 05:00 [medline]
PHST- 2003/12/05 05:00 [entrez]
PST - ppublish
SO  - Folia Morphol (Warsz). 2003 Nov;62(4):317-8.